MDK and neoplasm: The increased expression of MK and NANOG was associated with histologically high-grade tumors (moderately- and poorly-differentiated OSCC) and clinically adverse prognosis (late tumor stage and lower overall survival rate), compared to tumors with weak or negative expression of MK and NANOG.